Axsome Therapeutics, Inc. (AXSM)
246.34
+0.70
(+0.28%)
USD |
NASDAQ |
Jun 10, 16:00
246.00
-0.34
(-0.14%)
After-Hours: 06:09
Axsome Therapeutics Market Cap : 12.67B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 12.67B |
| June 09, 2026 | 12.63B |
| June 08, 2026 | 12.09B |
| June 05, 2026 | 11.95B |
| June 04, 2026 | 11.90B |
| June 03, 2026 | 12.01B |
| June 02, 2026 | 11.42B |
| June 01, 2026 | 11.84B |
| May 29, 2026 | 12.06B |
| May 28, 2026 | 11.97B |
| May 27, 2026 | 12.07B |
| May 26, 2026 | 12.05B |
| May 22, 2026 | 12.14B |
| May 21, 2026 | 12.02B |
| May 20, 2026 | 11.87B |
| May 19, 2026 | 11.66B |
| May 18, 2026 | 11.70B |
| May 15, 2026 | 11.72B |
| May 14, 2026 | 11.95B |
| May 13, 2026 | 12.11B |
| May 12, 2026 | 11.53B |
| May 11, 2026 | 11.14B |
| May 08, 2026 | 11.19B |
| May 07, 2026 | 11.33B |
| May 06, 2026 | 11.46B |
| Date | Value |
|---|---|
| May 05, 2026 | 11.48B |
| May 04, 2026 | 11.51B |
| May 01, 2026 | 10.63B |
| April 30, 2026 | 10.69B |
| April 29, 2026 | 9.466B |
| April 28, 2026 | 9.463B |
| April 27, 2026 | 9.586B |
| April 24, 2026 | 9.512B |
| April 23, 2026 | 9.347B |
| April 22, 2026 | 9.536B |
| April 21, 2026 | 9.360B |
| April 20, 2026 | 9.652B |
| April 17, 2026 | 9.667B |
| April 16, 2026 | 9.422B |
| April 15, 2026 | 9.421B |
| April 14, 2026 | 9.421B |
| April 13, 2026 | 9.122B |
| April 10, 2026 | 9.111B |
| April 09, 2026 | 9.151B |
| April 08, 2026 | 8.859B |
| April 07, 2026 | 8.632B |
| April 06, 2026 | 8.683B |
| April 02, 2026 | 8.620B |
| April 01, 2026 | 8.787B |
| March 31, 2026 | 8.646B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Indivior Pharmaceuticals, Inc. | 4.647B |
| Filana Therapeutics, Inc. | 63.77M |
| CorMedix, Inc. | 687.53M |
| Eloxx Pharmaceuticals, Inc. | 5.073M |
| Cannabis Global, Inc. | 0.6564M |
Market Cap Related Metrics
| PS Ratio | 17.50 |
| Price to Book Value | 232.05 |
| Price | 246.34 |
| Earnings Yield | -1.52% |